There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Accelerating Access to Critical Therapies for ALS Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To provide for the acceleration of access to clinical therapies for the treatment of amyotrophic lateral sclerosis, and for other purposes.


Actions Overview (1)

Date Actions Overview
06/01/2020Introduced in House

All Actions (2)

Date All Actions
06/01/2020Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
06/01/2020Introduced in House
Action By: House of Representatives

Cosponsors (198)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Quigley, Mike [D-IL-5]* 06/01/2020
Rep. Higgins, Clay [R-LA-3] 06/11/2020
Rep. Schweikert, David [R-AZ-6] 06/11/2020
Rep. Rouda, Harley [D-CA-48] 06/11/2020
Rep. Crow, Jason [D-CO-6] 06/11/2020
Rep. Sewell, Terri A. [D-AL-7] 06/11/2020
Rep. Fitzpatrick, Brian K. [R-PA-1] 06/11/2020
Rep. Calvert, Ken [R-CA-42] 06/11/2020
Rep. Hill, J. French [R-AR-2] 06/11/2020
Rep. Neguse, Joe [D-CO-2] 06/11/2020
Rep. Crawford, Eric A. "Rick" [R-AR-1] 06/11/2020
Rep. Harris, Andy [R-MD-1] 06/18/2020
Rep. Womack, Steve [R-AR-3] 06/18/2020
Rep. Cook, Paul [R-CA-8] 06/25/2020
Rep. Cole, Tom [R-OK-4] 06/25/2020
Rep. Brooks, Mo [R-AL-5] 06/25/2020
Rep. Fleischmann, Charles J. "Chuck" [R-TN-3] 07/21/2020
Rep. Sires, Albio [D-NJ-8] 07/21/2020
Rep. King, Steve [R-IA-4] 07/21/2020
Rep. Van Drew, Jefferson [R-NJ-2] 07/21/2020
Rep. Beatty, Joyce [D-OH-3] 07/21/2020
Rep. Davis, Rodney [R-IL-13] 07/21/2020
Rep. Golden, Jared F. [D-ME-2] 07/21/2020
Rep. Scanlon, Mary Gay [D-PA-5] 07/21/2020
Rep. Stivers, Steve [R-OH-15] 07/30/2020
Rep. Westerman, Bruce [R-AR-4] 07/30/2020
Rep. Stanton, Greg [D-AZ-9] 07/30/2020
Rep. Holding, George [R-NC-2] 07/30/2020
Rep. Timmons, William R. IV [R-SC-4] 07/30/2020
Rep. Moolenaar, John R. [R-MI-4] 07/30/2020
Rep. King, Peter T. [R-NY-2] 07/30/2020
Rep. Ruppersberger, C. A. Dutch [D-MD-2] 07/30/2020
Rep. Meeks, Gregory W. [D-NY-5] 07/30/2020
Rep. Turner, Michael R. [R-OH-10] 07/30/2020
Rep. McClintock, Tom [R-CA-4] 08/14/2020
Rep. O'Halleran, Tom [D-AZ-1] 08/14/2020
Rep. Riggleman, Denver [R-VA-5] 08/14/2020
Rep. DesJarlais, Scott [R-TN-4] 08/14/2020
Rep. Langevin, James R. [D-RI-2] 08/14/2020
Rep. Luria, Elaine G. [D-VA-2] 08/14/2020
Rep. Green, Al [D-TX-9] 08/14/2020
Rep. Soto, Darren [D-FL-9] 08/14/2020
Rep. Peterson, Collin C. [D-MN-7] 08/14/2020
Rep. Cisneros, Gilbert Ray, Jr. [D-CA-39] 08/14/2020
Rep. Katko, John [R-NY-24] 08/14/2020
Rep. Tlaib, Rashida [D-MI-13] 08/14/2020
Rep. Payne, Donald M., Jr. [D-NJ-10] 08/14/2020
Rep. Khanna, Ro [D-CA-17] 08/14/2020
Rep. Babin, Brian [R-TX-36] 08/14/2020
Rep. Craig, Angie [D-MN-2] 08/22/2020
Rep. Lowenthal, Alan S. [D-CA-47] 08/22/2020
Rep. Cooper, Jim [D-TN-5] 08/22/2020
Rep. Roybal-Allard, Lucille [D-CA-40] 08/22/2020
Rep. Scott, David [D-GA-13] 08/22/2020
Rep. Lieu, Ted [D-CA-33] 08/22/2020
Rep. Cunningham, Joe [D-SC-1] 08/22/2020
Rep. McCollum, Betty [D-MN-4] 08/22/2020
Rep. Smith, Jason [R-MO-8] 08/22/2020
Rep. Miller, Carol D. [R-WV-3] 08/22/2020
Rep. McMorris Rodgers, Cathy [R-WA-5] 08/22/2020
Rep. Brownley, Julia [D-CA-26] 08/22/2020
Rep. Yoho, Ted S. [R-FL-3] 08/22/2020
Rep. McKinley, David B. [R-WV-1] 08/22/2020
Rep. Weber, Randy K., Sr. [R-TX-14] 08/22/2020
Rep. LaMalfa, Doug [R-CA-1] 08/28/2020
Rep. Napolitano, Grace F. [D-CA-32] 08/28/2020
Rep. Lamb, Conor [D-PA-17] 08/28/2020
Rep. Waltz, Michael [R-FL-6] 08/28/2020
Rep. Davis, Susan A. [D-CA-53] 08/28/2020
Rep. Gonzalez, Vicente [D-TX-15] 08/28/2020
Rep. Stefanik, Elise M. [R-NY-21] 08/28/2020
Rep. Pappas, Chris [D-NH-1] 08/28/2020
Rep. Axne, Cynthia [D-IA-3] 08/28/2020
Rep. Speier, Jackie [D-CA-14] 08/28/2020
Rep. Moulton, Seth [D-MA-6] 08/28/2020
Rep. DeFazio, Peter A. [D-OR-4] 08/28/2020
Rep. McNerney, Jerry [D-CA-9] 09/04/2020
Rep. Bacon, Don [R-NE-2] 09/04/2020
Rep. Kelly, Trent [R-MS-1] 09/04/2020
Rep. Cicilline, David N. [D-RI-1] 09/04/2020
Rep. Wenstrup, Brad R. [R-OH-2] 09/04/2020
Rep. Lawson, Al, Jr. [D-FL-5] 09/04/2020
Rep. Gianforte, Greg [R-MT-At Large] 09/04/2020
Rep. Schneider, Bradley Scott [D-IL-10] 09/04/2020
Rep. Clay, Wm. Lacy [D-MO-1] 09/04/2020
Rep. Raskin, Jamie [D-MD-8] 09/04/2020
Rep. Pingree, Chellie [D-ME-1] 09/04/2020
Rep. Frankel, Lois [D-FL-21] 09/04/2020
Rep. Dean, Madeleine [D-PA-4] 09/04/2020
Rep. Dunn, Neal P. [R-FL-2] 09/04/2020
Rep. Demings, Val Butler [D-FL-10] 09/04/2020
Rep. Malinowski, Tom [D-NJ-7] 09/04/2020
Rep. Maloney, Sean Patrick [D-NY-18] 09/04/2020
Rep. Kilmer, Derek [D-WA-6] 09/04/2020
Rep. Amodei, Mark E. [R-NV-2] 09/04/2020
Rep. Meng, Grace [D-NY-6] 09/04/2020
Rep. Hern, Kevin [R-OK-1] 09/04/2020
Rep. Allred, Colin Z. [D-TX-32] 09/04/2020
Rep. Spanberger, Abigail Davis [D-VA-7] 09/04/2020
Rep. Ryan, Tim [D-OH-13] 09/15/2020
Rep. Loudermilk, Barry [R-GA-11] 09/15/2020
Rep. Garamendi, John [D-CA-3] 09/15/2020
Rep. Horn, Kendra S. [D-OK-5] 09/15/2020
Rep. Wittman, Robert J. [R-VA-1] 09/15/2020
Rep. Diaz-Balart, Mario [R-FL-25] 09/15/2020
Rep. Mullin, Markwayne [R-OK-2] 09/15/2020
Rep. Wild, Susan [D-PA-7] 09/15/2020
Rep. Kildee, Daniel T. [D-MI-5] 09/15/2020
Rep. Rutherford, John H. [R-FL-4] 09/15/2020
Rep. Huffman, Jared [D-CA-2] 09/15/2020
Rep. Welch, Peter [D-VT-At Large] 09/15/2020
Rep. Haaland, Debra A. [D-NM-1] 09/15/2020
Rep. Carson, Andre [D-IN-7] 09/15/2020
Rep. McBath, Lucy [D-GA-6] 09/15/2020
Rep. Lucas, Frank D. [R-OK-3] 09/15/2020
Rep. Velazquez, Nydia M. [D-NY-7] 09/15/2020
Rep. Kelly, Robin L. [D-IL-2] 09/15/2020
Rep. Biggs, Andy [R-AZ-5] 09/15/2020
Rep. Aguilar, Pete [D-CA-31] 09/16/2020
Rep. Tonko, Paul [D-NY-20] 09/16/2020
Rep. Norton, Eleanor Holmes [D-DC-At Large] 09/18/2020
Rep. Griffith, H. Morgan [R-VA-9] 09/18/2020
Rep. Keller, Fred [R-PA-12] 09/18/2020
Rep. Tiffany, Thomas P. [R-WI-7] 09/18/2020
Rep. Costa, Jim [D-CA-16] 09/22/2020
Rep. Cardenas, Tony [D-CA-29] 09/22/2020
Rep. Harder, Josh [D-CA-10] 09/22/2020
Rep. Rush, Bobby L. [D-IL-1] 09/22/2020
Rep. Kim, Andy [D-NJ-3] 09/22/2020
Rep. Flores, Bill [R-TX-17] 09/22/2020
Rep. Wasserman Schultz, Debbie [D-FL-23] 09/22/2020
Rep. Deutch, Theodore E. [D-FL-22] 09/22/2020
Rep. Thompson, Glenn [R-PA-15] 09/22/2020
Rep. Smith, Adrian [R-NE-3] 09/24/2020
Rep. Wexton, Jennifer [D-VA-10] 09/24/2020
Rep. Lamborn, Doug [R-CO-5] 09/24/2020
Rep. Hagedorn, Jim [R-MN-1] 09/24/2020
Rep. Kuster, Ann M. [D-NH-2] 09/24/2020
Rep. Bilirakis, Gus M. [R-FL-12] 09/24/2020
Rep. Delgado, Antonio [D-NY-19] 09/30/2020
Rep. McGovern, James P. [D-MA-2] 09/30/2020
Rep. Brindisi, Anthony [D-NY-22] 09/30/2020
Rep. Upton, Fred [R-MI-6] 09/30/2020
Rep. McCaul, Michael T. [R-TX-10] 10/01/2020
Rep. Joyce, David P. [R-OH-14] 10/01/2020
Rep. Suozzi, Thomas R. [D-NY-3] 10/01/2020
Rep. Clarke, Yvette D. [D-NY-9] 10/01/2020
Rep. Krishnamoorthi, Raja [D-IL-8] 10/01/2020
Rep. Rose, Max [D-NY-11] 10/01/2020
Rep. Bishop, Sanford D., Jr. [D-GA-2] 10/01/2020
Rep. Mast, Brian J. [R-FL-18] 10/01/2020
Rep. Watkins, Steve [R-KS-2] 10/01/2020
Rep. Zeldin, Lee M. [R-NY-1] 10/01/2020
Rep. Scott, Austin [R-GA-8] 10/01/2020
Rep. Evans, Dwight [D-PA-3] 10/01/2020
Rep. Davis, Danny K. [D-IL-7] 10/09/2020
Rep. Rice, Kathleen M. [D-NY-4] 10/09/2020
Rep. Gallego, Ruben [D-AZ-7] 10/09/2020
Rep. Chabot, Steve [R-OH-1] 10/09/2020
Rep. Cohen, Steve [D-TN-9] 10/09/2020
Rep. Slotkin, Elissa [D-MI-8] 10/09/2020
Rep. Gonzalez, Anthony [R-OH-16] 10/09/2020
Rep. Hastings, Alcee L. [D-FL-20] 10/09/2020
Rep. Houlahan, Chrissy [D-PA-6] 10/09/2020
Rep. Abraham, Ralph Lee [R-LA-5] 10/09/2020
Rep. Brooks, Susan W. [R-IN-5] 10/09/2020
Rep. Keating, William R. [D-MA-9] 10/09/2020
Rep. Ferguson, A. Drew, IV [R-GA-3] 10/09/2020
Rep. Huizenga, Bill [R-MI-2] 10/09/2020
Rep. Hayes, Jahana [D-CT-5] 10/13/2020
Rep. Simpson, Michael K. [R-ID-2] 10/13/2020
Rep. Posey, Bill [R-FL-8] 10/13/2020
Rep. Watson Coleman, Bonnie [D-NJ-12] 10/13/2020
Rep. Reschenthaler, Guy [R-PA-14] 10/13/2020
Rep. Boyle, Brendan F. [D-PA-2] 10/16/2020
Rep. Schiff, Adam B. [D-CA-28] 10/16/2020
Rep. Maloney, Carolyn B. [D-NY-12] 10/16/2020
Rep. Lee, Barbara [D-CA-13] 10/16/2020
Rep. DeSaulnier, Mark [D-CA-11] 10/16/2020
Rep. Schakowsky, Janice D. [D-IL-9] 10/16/2020
Rep. Thompson, Mike [D-CA-5] 10/16/2020
Rep. Roe, David P. [R-TN-1] 10/16/2020
Rep. Morelle, Joseph D. [D-NY-25] 10/20/2020
Rep. Stevens, Haley M. [D-MI-11] 10/20/2020
Rep. Lee, Susie [D-NV-3] 10/20/2020
Rep. Vargas, Juan [D-CA-51] 10/20/2020
Rep. Lynch, Stephen F. [D-MA-8] 10/20/2020
Rep. Barragan, Nanette Diaz [D-CA-44] 10/23/2020
Rep. Bishop, Rob [R-UT-1] 10/23/2020
Rep. Duncan, Jeff [R-SC-3] 10/23/2020
Rep. Pressley, Ayanna [D-MA-7] 10/23/2020
Rep. Swalwell, Eric [D-CA-15] 10/23/2020
Rep. Phillips, Dean [D-MN-3] 10/30/2020
Rep. Meuser, Daniel [R-PA-9] 10/30/2020
Rep. Steube, W. Gregory [R-FL-17] 10/30/2020
Rep. Wilson, Joe [R-SC-2] 10/30/2020
Rep. Garcia, Mike [R-CA-25] 10/30/2020
Rep. Clark, Katherine M. [D-MA-5] 10/30/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce06/01/2020 Referred to

As of 10/31/2020 no related bill information has been received for H.R.7071 - Accelerating Access to Critical Therapies for ALS Act


Latest Summary (1)

There is one summary for H.R.7071. View summaries

Shown Here:
Introduced in House (06/01/2020)

Accelerating Access to Critical Therapies for ALS Act

This bill establishes a grant program, as well as a new center within the Food and Drug Administration (FDA), to facilitate access to investigational therapies for neurodegenerative diseases such as amyotrophic lateral sclerosis (i.e., ALS, also known as Lou Gehrig's disease, a progressive and fatal disease).

Specifically, the Department of Health and Human Services (HHS) must award grants for the provision of investigational drugs for ALS and other rapidly progressing neurodegenerative diseases through an expanded access (i.e., compassionate use) program. HHS may award these grants to (1) a small business that is the sponsor of an investigational new drug application, or (2) a participating clinical trial site for such a sponsor.

Additionally, HHS must establish within the FDA a Center of Excellence for Neurodegenerative Diseases. The center shall have duties and authorities similar to those of the FDA's Oncology Center of Excellence, which helps expedite the development of medical products and assists providers in requesting access to investigational drugs.